X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 53 filers reported holding X4 PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,115 | -68.4% | 27,628 | -43.7% | 0.00% | – |
Q2 2023 | $95,157 | +14427.8% | 49,050 | +6413.9% | 0.00% | – |
Q1 2023 | $655 | +54.5% | 753 | +76.3% | 0.00% | – |
Q4 2022 | $424 | -57.6% | 427 | -26.3% | 0.00% | – |
Q3 2022 | $1,000 | – | 579 | +242.6% | 0.00% | – |
Q2 2022 | $0 | – | 169 | +19.0% | 0.00% | – |
Q1 2022 | $0 | – | 142 | +13.6% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 125 | 0.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 125 | -5.3% | 0.00% | – |
Q2 2021 | $1,000 | -97.9% | 132 | -97.6% | 0.00% | – |
Q1 2021 | $48,000 | -72.4% | 5,579 | -79.5% | 0.00% | – |
Q4 2020 | $174,000 | +95.5% | 27,156 | +105.0% | 0.00% | – |
Q3 2020 | $89,000 | -45.4% | 13,244 | -24.0% | 0.00% | – |
Q2 2020 | $163,000 | -32.6% | 17,419 | -27.8% | 0.00% | – |
Q1 2020 | $242,000 | -4.0% | 24,136 | +2.6% | 0.00% | – |
Q4 2019 | $252,000 | -13.7% | 23,534 | +2.6% | 0.00% | – |
Q3 2019 | $292,000 | +71.8% | 22,935 | +102.5% | 0.00% | – |
Q2 2019 | $170,000 | +2025.0% | 11,327 | +2456.9% | 0.00% | – |
Q1 2019 | $8,000 | – | 443 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |